Barclays’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-1,760
Closed -$1.99M – 6824
2019
Q2
$1.99M Buy
1,760
+1,720
+4,300% +$1.88M ﹤0.01% 2931
2019
Q1
$54K Hold
40
– – ﹤0.01% 5816
2018
Q4
$46K Buy
+40
New +$45K ﹤0.01% 5517

Other funds holding KYNB

Barclays's KYNB Position: Q3 2026 in Review

Barclays opened a new position in Kyntra Bio (KYNB) in Q3 2026: 3 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #5126 among its holdings. This is a return to the name: Barclays previously reported a position in KYNB as recently as Q2 2024.

Barclays first reported a position in KYNB in Q4 2014 and has held it in 39 quarters since. The position peaked at $8.1M in Q4 2019. 35 funds tracked by Wall St. Rank hold KYNB as of Q3 2026.

  • Barclays held 3 shares of Kyntra Bio worth $20 as of Q3 2026.
  • Kyntra Bio was a new Barclays position in Q3 2026.
  • Kyntra Bio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5126 holding.
  • Barclays first reported a position in Kyntra Bio in Q4 2014 and has held it in 39 quarters since.
  • Barclays's Kyntra Bio position peaked at $8.1M in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.